Elsevier

Atherosclerosis

Volume 138, Issue 2, June 1998, Pages 229-235
Atherosclerosis

The atherogenic lipoprotein phenotype and vascular endothelial dysfunction

https://doi.org/10.1016/S0021-9150(98)00037-9Get rights and content

Abstract

There is accumulating evidence that elevated plasma triglycerides and related abnormalities constitute an independent cardiovascular risk factor. Although the pathogenetic basis for the apparent relationship between elevated triglyceride-rich lipoproteins and CAD is still uncertain, evidence is accumulating to suggest that endothelial dysfunction is involved. There is evidence to suggest that triglyceride-rich particles may be directly damaging to the endothelium; this may be principally via oxidative mechanisms. Triglyceride-rich particles can cross the endothelial barrier and enter the arterial wall, thus placing them in a position to promote direct endothelial damage. These particles stimulate endothelial expression of adhesion molecules and the prothrombotic factor PAI-1. By reducing LDL size and HDL cholesterol concentrations, thereby further increasing the endothelial oxidative burden, triglyceride-rich particles may indirectly promote endothelial dysfunction. In addition, free fatty acids, which are the major substrates for endogenous synthesis of triglyceride-rich particles, are also potentially damaging to the endothelium. This occurs via oxidative stress, by facilitating transfer of LDL across the endothelium, and by enhancing toxicity of triglyceride-rich particles. Finally, there is recent strong evidence to suggest that increased postprandial circulating concentrations of triglyceride-rich particles and remnant particles may be deleterious to the endothelium.

Introduction

Plasma low density lipoprotein-cholesterol (LDL-cholesterol) has long been regarded as the key lipid fraction in the pathogenesis of atherosclerosis. This view has recently been reinforced by the results of studies showing that lowering plasma LDL cholesterol concentrations using statins is an effective primary and secondary prevention measure for coronary artery disease (CAD) 1, 2. However, there is accumulating evidence that elevated plasma triglycerides and related abnormalities constitute an independent cardiovascular risk factor at least as important as cholesterol 3, 4, 5, 6, 7. Raised plasma triglyceride-rich lipoproteins are associated with low high-density lipoprotein cholesterol (HDL-cholesterol) and small, dense LDL particles and together comprise the atherogenic lipoprotein phenotype (ALP) [8]. The clinical importance of this ALP pattern probably exceeds that of LDL-cholesterol, because many more CAD patients are found to have this trait than hypercholesterolaemia [9]. The pathogenetic basis for the apparent relationship between elevated triglyceride-rich lipoproteins and CAD is still uncertain. We propose that endothelial damage, in part mediated by increased oxidative stress, is one mechanism whereby elevated triglyceride-rich particles (and related metabolic features) may be causally associated with atherogenesis.

Section snippets

The atherogenic lipoprotein profile, insulin resistance and free fatty acids

Elevations in free fatty acids (FFAs) are observed in abdominal obesity, non-insulin dependent diabetes mellitus (NIDDM) and other insulin resistant states [10]. FFAs are the major substrates for hepatic triglyceride synthesis [11]and impaired suppression of circulating plasma levels of FFAs by insulin plays a major role in the initiation of the atherogenic lipoprotein cascade. The consequent increased hepatic secretion of triglyceride-rich very low density lipoprotein (VLDL) into the plasma

Endothelium and endothelial dysfunction

The vascular endothelium is an active organ, synthesising and responding to vasodilator and vasoconstrictor agents, regulating the balance between thrombosis and fibrinolysis, and interacting with monocytes and inhibiting platelet activity [14]. Production of the inorganic gas nitric oxide (NO) is believed to be integral to many of these functions. NO, formed from l-arginine by a constitutive form of the enzyme nitric oxide synthase, inhibits platelet aggregation and adhesion, modulates smooth

Oxidative stress

Available evidence suggests that the extent of endothelial vasodilator dysfunction might reflect the degree of oxidative stress imposed on the endothelium by cardiovascular risk factors. This assumption is based upon reports that antioxidants such as vitamin E and vitamin C, and probucol ameliorate the degree of endothelial vasomotor dysfunction 23, 25, and in the case of vitamin E improve coronary outcome 26, 27. Excessive production of reactive species in the form of superoxide anions in

Summary

We have reviewed the possible mechanisms by which elevations in triglyceride-rich lipoproteins (and related metabolic perturbances) may mediate endothelial dysfunction. There is evidence to suggest that triglyceride-rich particles may be directly damaging to the endothelium; this may be principally via oxidative mechanisms. Triglyceride-rich particles can cross the endothelial barrier and enter the arterial wall, thus placing them in a position to promote direct endothelial damage. These

References (72)

  • M.I. Mackness et al.

    Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

    FEBS Lett

    (1991)
  • B. Hennig et al.

    Disruption of endothelial barrier function by lipolytic remnants of triglyceride-rich lipoproteins

    Atherosclerosis

    (1992)
  • R.A. Vogel et al.

    Effect of a single high-fat meal on endothelial function in healthy subjects

    Am J Cardiol

    (1997)
  • H.C.R. Simpson et al.

    Hypertriglyceridaemia and hypercoagulability

    Lancet

    (1983)
  • S.A.P. Karabina et al.

    Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions

    Biochim Biophys Acta

    (1994)
  • C.W. Laughton et al.

    Sera containing elevated nonesterified fatty acids from patients with angiographically documented coronary atherosclerosis cause marked lipid accumulation in cultured human arterial smooth muscle-derived cells

    Atherosclerosis

    (1988)
  • B.W. Arbogast

    Purification and identification of very low density lipoprotein toxicity preventing activity

    Atherosclerosis

    (1988)
  • M. Toborek et al.

    Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells

    Am J Clin Nutr

    (1994)
  • J. Shepherd et al.

    Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia

    N Eng J Med

    (1995)
  • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease

    Lancet

    (1994)
  • J.E. Hokanson et al.

    Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies

    J Cardiovasc Risk

    (1996)
  • H.N. Hodis et al.

    Triglyceride- and cholesterol-rich lipoprotein have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

    Circulation

    (1994)
  • M.J. Stampfer et al.

    A prospective study of triglycerides, LDL particle diameter and risk of myocardial infarction

    J Am Med Assoc

    (1996)
  • M.A. Austin et al.

    Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes

    Curr Opin Lipidol

    (1996)
  • H.R. Superko

    Beyond LDL cholesterol reduction

    Circulation

    (1996)
  • G. Boden

    Role of fatty acids in the pathogenesis of insulin resistance and NIDDM

    Diabetes

    (1996)
  • C.E. Tan et al.

    Relationship between very low and low density lipoprotein subfractions in normolipaemic men and women

    Arterioscler Thromb Vasc Biol

    (1995)
  • C.F. Ebenbichler et al.

    Postprandial state and atherosclerosis

    Curr Opin Lipidol

    (1995)
  • A.M. Zeiher

    Endothelial vasodilator dysfunction: pathogenetic link to myocardial ischaemia or epiphenomenon?

    Lancet

    (1996)
  • G.N. Levine et al.

    Cholesterol reduction and cardiovascular disease

    N Eng J Med

    (1995)
  • H.M. Loree et al.

    Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels

    Circ Res

    (1992)
  • A.M. Zeiher et al.

    Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis

    Circulation

    (1993)
  • J.A. Panza et al.

    Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension

    Circulation

    (1993)
  • G.E. McVeigh et al.

    Impaired endothelium dependent and independent vasodilation in patients with type 2 (non-insulin dependent) diabetes mellitus

    Diabetologia

    (1992)
  • H. Steinberg et al.

    Obesity/insulin resistance is associated with endothelial dysfunction

    J Clin Invest

    (1996)
  • T.J. Anderson et al.

    The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

    N Engl J Med

    (1995)
  • Cited by (0)

    View full text